EdiTy Therapeutics
Sharon is an experienced biochemist and renowned oligo nucleotides expert. At QBI, she headed the entire planning of pre-clinical studies the pre-clinical siRNA pipeline, including in vitro and in vivo trials.
This person is not in any offices
EdiTy Therapeutics
EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells.